In a concerted effort to eliminate malaria, the Oversight Committee of the MOSASWA (Mozambique, South Africa, and Eswatini) Regional Coordinating Mechanism (RCM), in collaboration with the Lebombo Spatial Development Initiative 2 (LSDI2), is preparing for a critical joint site visit. Led by Dr. Ednah Baloyi, Director of Malaria and Other Vector-Borne Diseases, the visit aims to assess program performance and its impact on communities in the Tzaneen and Giyani districts, as well as the Collins Chabane Surveillance site within Limpopo Province.
Scheduled for May 8th to 10th, 2024, the visit holds the purpose of evaluating the program’s performance against predefined goals. Specifically, it seeks to gauge the program's effectiveness in eliminating malaria and its impact on the communities served by the grant. The Oversight Committee, accompanied by key stakeholders including the South African Medical Research Council (SAMRC), Lebombo Spatial Development Initiative 2 (LSDI2), Clinton Health Access Initiative (CHAI), and Humana People to People SA (HPPSA), aims to delve into the program's intricacies during the visit.
The Oversight Committee is tasked with various objectives, including planning, coordinating, and executing oversight of Global Fund grants on behalf of the RCM. During the visit, the committee will conduct thorough assessments of LSDI2's performance and grant progress using key indicators. Additionally, it will track management, gather feedback from beneficiary constituencies, analyze grant reports and audits, and identify bottlenecks in the performance framework indicators.
The success of the efforts in malaria elimination relies heavily on effective collaboration and robust oversight. By conducting joint site visits and engaging with local communities and stakeholders, the aim is to ensure that programs are effectively addressing the challenges posed by malaria.
